Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karina Dahl Steffensen

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 19, 2022
Welcome to the "International Shared Decision Making Conference 2022"Karina Dahl Steffensen
JCO Oncology Practice|August 13, 2025
Shared Decision Making Can-and Should-Actively Involve Family CaregiversKarina Dahl Steffensen, Leonard Berry
Journal of Patient-Reported Outcomes|August 12, 2024
Translation and cultural adaption of the control preference scale across various care settings in a Danish hospitalBettina Mølri Knudsen, Karina Dahl Steffensen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 2, 2017
Veliparib Monotherapy to Patients With BRCA Germ Line Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer: A Phase I/II StudyKarina Dahl Steffensen, Parvin Adimi, Anders Jakobsen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 4, 2009
The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancerKarina Dahl Steffensen, Marianne Waldstrøm, Anders Jakobsen
Ugeskrift for Laeger|February 3, 2018
[Treatment of primary and recurrent ovarian cancer]Mikkel Rosendahl, Berit Jul Mosgaard, Karina Dahl Steffensen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 9, 2011
Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patientsKarina Dahl Steffensen, Marianne Waldstrøm, Ivan Brandslund, et al.
Journal of Evaluation in Clinical Practice|May 30, 2019
The impact of a patient decision aid on shared decision-making behaviour in oncology care and pulmonary medicine-A field study based on real-life observationsKarina Olling, Mette Stie, Bodil Winther, et al.
Cancer Treatment and Research Communications|August 15, 2018
Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA statusMette Hjortkjær, Hanne Kanstrup, Anders Jakobsen, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 23, 2017
Implementing shared decision making in Denmark: First steps and future focus areasKarina Dahl Steffensen, Vibe Hjelholt Baker, Mette Marianne Vinter
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 19, 2022
Welcome to the "International Shared Decision Making Conference 2022"Karina Dahl Steffensen
JCO Oncology Practice|August 13, 2025
Shared Decision Making Can-and Should-Actively Involve Family CaregiversKarina Dahl Steffensen, Leonard Berry
Journal of Patient-Reported Outcomes|August 12, 2024
Translation and cultural adaption of the control preference scale across various care settings in a Danish hospitalBettina Mølri Knudsen, Karina Dahl Steffensen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 2, 2017
Veliparib Monotherapy to Patients With BRCA Germ Line Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer: A Phase I/II StudyKarina Dahl Steffensen, Parvin Adimi, Anders Jakobsen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 4, 2009
The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancerKarina Dahl Steffensen, Marianne Waldstrøm, Anders Jakobsen
Ugeskrift for Laeger|February 3, 2018
[Treatment of primary and recurrent ovarian cancer]Mikkel Rosendahl, Berit Jul Mosgaard, Karina Dahl Steffensen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 9, 2011
Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patientsKarina Dahl Steffensen, Marianne Waldstrøm, Ivan Brandslund, et al.
Journal of Evaluation in Clinical Practice|May 30, 2019
The impact of a patient decision aid on shared decision-making behaviour in oncology care and pulmonary medicine-A field study based on real-life observationsKarina Olling, Mette Stie, Bodil Winther, et al.
Cancer Treatment and Research Communications|August 15, 2018
Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA statusMette Hjortkjær, Hanne Kanstrup, Anders Jakobsen, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 23, 2017
Implementing shared decision making in Denmark: First steps and future focus areasKarina Dahl Steffensen, Vibe Hjelholt Baker, Mette Marianne Vinter
Pageof 11